Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US > DEA Meetings & Events > Pharmaceutical Training Seminars > May 8-9, 2017 & May 10-11, 2017; Minneapolis, Minnesota

Pharmaceutical Training Seminars

May 8-9, 2017 & May 10-11, 2017 – Minneapolis, Minnesota

Introduction

The Drug Enforcement Administration (DEA), Diversion Control Division, sponsored two Pharmaceutical Training Seminars, May 8-9, and May 10-11, 2017 at the Hilton Minneapolis, in Minneapolis, Minnesota. Attendees included approximately, 116 DEA registered manufacturers and importers/exports of Schedule 1 and II controlled substances, and the CMEA List 1 chemicals. The purpose of these pharmaceutical training seminars is to assist non-managerial DEA compliance personnel of the DEA registered manufacturing, importing, and exporting companies on the CSA, quotas, year-end reporting, ARCOS reporting, import/export permits and declarations, scheduled investigations, the Combat Methamphetamine Epidemic Act (CMEA) and the Controlled Substance Ordering System (CSOS). The seminars also included content regarding the registration process for manufacturers and importers of Schedule I and II controlled substances, and the CMEA List 1 chemicals. These conferences are one of the mechanisms used by the Diversion Control Division to foster communication and cooperation with its registrants in complying with the Controlled Substances Act and its implementing regulations, as well as their vigilance in identifying and preventing diversion.

Conference Presentations

Welcome Remarks and Introduction to the Seminars – Kimberly Brill, Group Supervisor, Minneapolis District Office

International Treaty Compliance – Gregory Kavanagh, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ and Suzanne Lenhard, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ

Registration of Manufacturers and Importers (Section 303 Investigations) – Scott Doubet, Unit Chief, Regulatory Unit, DEA HQ

Import/Export – Dawin Cruz Gonzales, Import Export Specialist, Import Export Unit, DEA HQ

Quotas – Gregory Kavanagh, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ and Suzanne Lenhard, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ

Research vs. Manufacturer – Gregory Kavanagh, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ and Suzanne Lenhard, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ

Quota Applications (online submissions) – Gregory Kavanagh, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ and Suzanne Lenhard, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ

Inventories, Records and Reports and Drug Theft Loss – Scott Doubet, Unit Chief, Regulatory Unit, DEA HQ

Diversion Investigator – How DEA approaches & completes a Regulatory Investigation, What to Expect – Scott Garriott, Diversion Investigator, DEA Springfield Resident Office

Year End Report (online submission) – Gregory Kavanagh, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ and Suzanne Lenhard, Drug Science Specialist, Quota & UN Reporting Unit, DEA HQ

Controlled Substance Ordering System (CSOS) – Christopher Jewell, Information Technology Specialist, Diversion Technology Section, DEA HQ

Automated Reports & Consolidated Order System (ARCOS) Reporting (Online submission) – Sam Weisman, Data Systems Analyst, ARCOS Unit, DEA HQ

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility